Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Books 43-Percent Increase in Revenues, 30 Percent Rise in Earnings in Q1

NEW YORK, April 29 (GenomeWeb News) - Molecular Devices yesterday reported increased revenues and profits for the first quarter of 2005.

 

Revenues for the quarter were $39.1 million, up year-over-year from $27.3 million. Both the life sciences and drug discovery product areas contributed to the growth.

 

Research and development costs increased to $6.2 million from $4 million during the year-ago period.

 

The company's net income for the quarter totaled $2.2 million, or $.13 per share, up from $1.4 million, or $.10 per share, during last year's first quarter.

 

As of March 31, Molecular Devices had $8.3 million in cash and cash equivalents.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.